Introduction
Complement fragment C5a is a potent pro-inflammatory 74-residue polypeptide (Gallin et al., 1991) with a well-defined structure consisting of a helical N-terminus, a disulfide-linked, antiparallel three-helix core and a loop-helix C-terminal domain (Zuiderweg et al., 1989; Zhang et al., 1997) . The full agonist potential of C5a is located in the C-terminal decapeptide whereas the remainder of the molecule confers high-affinity binding to the cell surface receptor Bubeck et al., 1994; Toth et al., 1994) . The agonist decapeptide is rapidly modified in vivo by serum carboxypeptidase activity which removes the C-terminal arginine residue (Bokisch and Muller-Eberhardt, 1974) . The desarginated (C5adR 74 ) form has a different pattern of activity to intact C5a. For instance, human mast cell degranulation is 10 3 -10 4 -fold less sensitive to C5adR 74 than to intact C5a (El-Lati et al., 1994; Fureder et al., 1995; Werfel et al., 1996) , whereas both forms are equipotent stimulants of fibroblast chemotaxis (Senior et al., 1988) . Despite the ligand selectivity demonstrated by different cell types, only a single receptor for C5a (C5aR) has so far been cloned, which is a member of the G protein-coupled receptor superfamily (Boulay et al., 1991; Gerard and Gerard, 1991) . The mechanism by which a single receptor type can display ligand selectivity in different cellular backgrounds has © Oxford University Press 189 begun to be elucidated. We have shown that the mutation of receptor residue E 199 to K completely inhibits activation by C5adR 74 but has little effect on the response to intact C5a (Monk et al., 1995) . The activity of C5adR 74 on these mutant receptors can be partly recovered by mutating ligand residue K 68 to E, presumably restoring an essential interaction with the receptor residue at position 199 (Crass et al., 1999) .
Recently, a phage display system has been used to select functional sequences from libraries of C5a molecules that had undergone random mutation between residues 69 and 73 (Hennecke et al., 1998) . A novel C5aR antagonist has been derived in this way which can inhibit C5a-mediated inflammatory events in vivo (Hennecke et al., 1998; Heller et al., 1999) . However, the display of functional C5a sequences on the phage surface and the choice of the pentapeptide randomized region relied heavily on data from previous studies of the C5a/C5aR system. We have recently extended this approach, combining phage display with a whole-molecule random mutagenesis technique that uses synthetic nucleotide triphosphates to introduce mutations throughout a protein by polymerase chain reaction (PCR) (Cain et al., 2000) . Here we report the production of novel ligands with increased affinity for the C5a receptor in the absence of prior assumptions about the particular residues involved in ligand-receptor interactions. Additional site-directed mutagenesis of these ligands was then used to produce C5aR antagonists.
Materials and methods

Materials
The C5a cDNA was kindly by provided Wilfried Bautsch (Medizinische Hochschule, Hannover, Germany). CHO cells transfected with wild-type and RBL cells transfected with wild-type C5aR were maintained in Dulbecco's Modified Eagle's Medium (DMEM), supplemented with 10% (v/v) fetal calf serum and 400 µg/ml G418 (Gibco BRL, UK). Mutagenic nucleotide triphosphates dP {6-(2-deoxy-β-D-ribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2] oxazin-7-one}, 8-oxodG (8-oxo-2Ј-deoxyguanosine) and 8-oxodG (8-oxo-2Ј-deoxyguanosine) were prepared as described previously (Zaccolo et al., 1996) or purchased from AmershamPharmacia (UK).
Construction of the C5adR 74 mutant library
The phagemid vector pJ/F2SS was used for expression of the C5adR 74 mutant libraries. pJ/F2SS is a modified version of the phagemid vector pJunFos (Crameri and Suter, 1993) with the second lacZ promoter removed and the second pelB leader sequence replaced by ompA (Cain et al., 2000) . The mutant C5adR 74 library was generated by PCR using the template of C5adR 74 as described previously (Zaccolo et al., 1996; Cain et al., 2000) . The structure of the modified phage is shown schematically in Figure 1a . Briefly, construction of the mutant C5adR 74 library involved two PCR reactions. The first PCR reaction, in the presence of the mutagenic nucleotide analogues, introduced mutations at a theoretical rate of 5-10 mutations per molecule. The PCR product was purified and used as template for a second 'wash-out' PCR reaction, containing no mutagenic nucleotide analogues. The size of the resultant C5adR 74 library expressed as phage was estimated as 1ϫ10 6 transformants. Affinity enrichment of the mutant library Selection of receptor binding clones from the mutant C5adR 74 library was performed on CHO cells transfected with human C5aR as described previously (Cain et al., 2000) . Briefly, 5ϫ10 6 cells were harvested, washed and resuspended in 0.5 ml of DMEM medium containing 1% (w/v) BSA, 20 mM HEPES pH 7.2 (DWB). The phages were added in 1 ml of DWB and incubated at room temperature for 30 min on a rotary mixer. After washing five times in 10 ml of DWB, the cells were resuspended in 0.5 ml of sterile PBS and the bound phages were eluted in 0.5 ml of 0.2 M HCl for 1 min. The supernatant was neutralized with 30 µl of 2 M Tris and a small sample of the phage was diluted to calculate the phage titre, by mixing 10 µl of diluted phages with 50 µl of freshly grown TG1 (OD 600 ϭ 1.0) and plating on to LB agarcarbenicillin. The remainder of the phages were amplified for the next round of selection by addition to 5 ml of freshly grown TG1 cells (OD 600 1.0) and incubated at room temperature for 15 min without shaking.
Expression and purification of C5adR 74 and mutants
Expression and purification of the recombinant His 6 -tagged C5a, C5adR 74 and the C5adR 74 variants was performed as described (Paczkowski et al., 1999) . For cleavage of the His 6 tag from C5adR 74 fragments, 200-300 µg of purified recombinant protein were digested with 100 U of rTEV protease in 1 mM DTT and rTEV buffer for 4 h at 30°C. The digested polypeptides were separated from the rTEV protease and cleaved His 6 tag by addition of Ni 2ϩ -NTA resin. A short sequence (GGS) remains at the N-terminus of the polypeptides in this production protocol (Figure 1b) . The presence of this N-terminal tripeptide appears to decrease the receptor affinity for GGS-C5adR 74 4-fold relative to native C5adR 74 but has no effect on C5a (Crass et al., 1999; Paczkowski et al., 1999) .
Measurement of receptor activation of RBL cells
Cellular activation was measured as the release of β-hexosaminidase activity from RBL-2H3 cells transfected with human C5aR as described previously (Cain et al., 2000) . The percentage of β-hexosaminidase release was calculated as a percentage 190 of the maximum release (1 µM C5a) sample. Typically, this concentration of C5a caused the release of 45% of the total cell-associated β-hexosaminidase activity. Assay of the antagonist activity of the C5adR 74 variants was performed as described above except that the antagonists were added at various concentrations for 15 min at 37°C after preincubation with release buffer. The agonists were then added at a final concentration of 10 nM (C5a) or 25 nM (C5adR 74 ) and incubated as normal. Data were analysed by GraphPad Prism software and significance was assessed by a t-test.
[ 125 I]C5a binding assay Binding assays using 50 pM [ 125 I]C5a were performed on adherent C5aR-transfected RBL cells in 96-well microtitre plates as described previously (Monk et al., 1994) .
Results
Selection from C5adR 74 mutant library
A randomly mutated C5adR 74 library with an amino acid mutation rate of 12.3% or nine substitutions per molecule was generated by PCR ( Figure 1a ). The mutations were distributed evenly through the sequence (data not shown). After three rounds of selection for receptor binding, a distinct pattern of mutations emerged with an average of 5.7 substitutions per molecule ( Table Ia) . The selected sequences fell into two distinct variant families: Variant 1 (K 14 R, C 27 R, P 45 S, I 48 T, G 73 R) and Variant 2 (K 4 R, S 16 P, C 27 R, V 56 A, V 57 A, D 69 N, M 70 T) ( Table Ia) . Three other sequences were obtained that all contained C 27 R; two of these were also R 73 and thus similar to Variant 1.
To isolate only the highest affinity mutant C5adR 74 sequences, two further rounds of selection were performed on Library 1, in the presence of 10 and 25 nM C5a, respectively. This limited the library to copies of Variant 2, with an average of 6.6 substitutions per molecule (Table Ib) . The single exception was similar to Variant 2 except that D 69 and M 70 were unchanged and G 73 was mutated to R, as in Variant 1.
Receptor binding and activation by C5adR 74 variants
We were interested to see how the mutations present in the two variants affected the agonist function of the free protein (Figure 1b) . Measured as the ability to compete for receptor binding with [I 125 ]C5a, Variant 1 and Variant 2 had similar affinities for the human C5aR on transfected RBL cells, with IC 50 ϭ 135 and 138 nM, respectively (Figure 2) . However, the variants had affinities that were~5-fold higher than GGSC5adR 74 (IC 50 ϭ 617 nM). The selected variants were then adapted by mutating K 68 to E, a change previously shown to inhibit C5aR activation by C5adR 74 but not by C5a (Monk et al., 1995; Crass et al., 1999) . After mutation at K 68 , the IC 50 values of the variants had increased (Variant 1[E 68 ] ϭ 3.1 µM; Variant 2[E 68 ] ϭ 1.6 µM) but were still much lower than that of GGS-C5adR 74 [E 68 ] (IC 50 Ͼ 20 µM) (Figure 2) .
The agonist activity of the selected Variants was measured using RBL cells transfected with human C5aR. GGS-C5adR 74 itself is only a partial agonist in this system (Figure 3) , with a maximal response of only 50% of intact GGS-C5a but with a similar EC 50 (EC 50 values for GGS-C5a and GGS-C5adR 74 ϭ 4.2 and 8.8 nM, respectively). In contrast, the two Variants of GGS-C5adR 74 were potent, full agonists (EC 50 values for Variant 1 and Variant 2 ϭ 8.6 and 5.7 nM, respectively) ( Figure 3 ) despite their apparently poor binding affinity in competition with [I 125 ]-C5a. After mutation at K 68 , Variant (Figure 3 ). Variant 1 [E 68 ] activated the C5aR to 20% of the response to intact GGS-C5a at 1 µM, but at 10 µM this had declined to control levels.
Antagonist activity of [Glu 68 ] variants
The [E 68 ] variants bound to the C5aR but were almost inactive and so were tested for their ability to act as antagonists of GGS-C5a and GGS-C5adR 74 . Both were full antagonists of GGS-C5adR 74 activity (Figure 4a 
Discussion
C5a has been extensively characterized and has a known structure and functionality and so it represents an excellent test system for ligand modification by whole-molecule random mutagenesis and phage display. In this study, we produced a library of randomly mutated C5adR 74 molecules and subjected them to selection for binding activity for the human C5aR expressed on the surface of CHO cells. Not surprisingly, the mutants selected from the library on the basis of receptor binding showed a complete absence of mutation of the key receptor-interacting basic residues [K 19 , K 20 , R 37 , R 40 , R 46 , K 49 , K 68 Bubeck et al., 1994; Zhang et al., 1997) ] and the C residues (C 21, 22 , 192 C 34 , C 47 , C 54,55 ) known to form intramolecular disulphide bridges Bubeck et al., 1994; Zhang et al., 1997) . C 27 , which is mutated in all selected sequences, has been shown not to form a disulphide bridge (Zimmermann and Vogt, 1984) and the ubiquitous mutation of C 27 R may simply be an adaptation to phage display. This was found previously for sequences selected from a randomly mutated intact C5a library (Cain et al., 2000) . The mutations in the C-terminal domain (G 73 R, D 67 N, M 70 T) are more likely to influence the binding affinity of the variants when expressed as free protein, perhaps by allowing the formation of the loophelix found at the C-terminus of C5a (Zhang et al., 1997) but not C5adR 74 (Zuiderweg et al., 1989) . Certainly, these residues were not mutated in sequences selected from an intact C5a library, suggesting that the mutations are specific for C5adR 74 function (Cain et al., 2000) .
In the absence of structural information on the mutant C5adR 74 molecules, it is possible only to speculate on the consequences of the particular mutations. The gain or loss of the two P residues (both of which occur in loops connecting helices) may have consequences for the relative positioning of those helix pairs. The mutation of S 16 P may affect the position of the N-terminal helix, which links the molecule to the phage particle, optimizing the display position of the C5a for receptor interaction. The presence of P 16 is associated with K 4 R in Variant 2. An attractive alternative explanation may be that P 16 coincidentally increases the proximity of residue 4 to the C-terminus, allowing R 4 partly to replace R 74 in Variant 2. In Variant 1, the mutation of G 73 to R might have a similar effect. The substantial differences in the mutation patterns between selected C5a and C5adR 74 libraries (Cain et al., 2000, and results presented here) are confirmation that these ligands interact with the C5aR in different ways (Crass et al., 1999) . The smaller variety of substitutions in the latter may be due to the deleterious effect of mutations on the binding mode of C5adR 74 . The more optimal binding mode of C5a may allow more mutations whilst retaining sufficient affinity to be selected in these conditions. Variants 1 and 2 had similar affinities for the human C5aR on transfected RBL cells. This contrasts with the selection of the phage-conjugated polypeptides (Figure 1a) , when Variant 2, but not Variant 1, was selected in the presence of increasing concentrations of GGS-C5a. However, the variants had affinities that were considerably higher than that of GGS-C5adR 74 , suggesting that the increased affinities of the phage-conjugated variants were retained in the free polypeptides. In a previous study of selection from a whole-molecule randomly mutated library of full-length C5a, the free polypeptides had a lower receptor affinity than the phage conjugates (Cain et al., 2000) . Interestingly, native C5adR 74 (i.e. without the N-terminal tripeptide extension introduced during production as a His 6 -tagged protein) has a 4-fold higher receptor-binding affinity than the GGS-C5adR 74 form (Figure 1b ) used in this study. The full-length C5a is not affected by the N-terminal tripeptide extension (Crass et al., 1999; Paczkowski et al., 1999) . Hence the mutagenesis and selection procedure has produced variants of GGS-C5adR 74 that are able to tolerate these additions at the N-terminus and therefore which resemble intact C5a in this respect. Previous work using GGS-C5a has shown that the receptor binding affinity is decreased only slightly by the mutation of K 68 to E 68 whereas the affinity for GGS-C5adR 74 is decreased considerably (Crass et al., 1999 ; results presented here). However, the affinities of the variants decreased consid-erably when mutated at K 68 , so in this respect, the variants resemble GGS-C5adR 74 more closely than GGS-C5a. The almost complete loss of agonist potential of the E 68 variants also suggests that the variants interact with the receptor identically with GGS-C5adR 74 . In contrast, Variants 1 and 2 were full agonists at the C5aR (unlike GGS-C5adR 74 ), suggesting a closer resemblance to GGS-C5a. Overall, the selected variants appear to have properties intermediate between those of full-length C5a and C5adR 74 . The mutations selected in the phage display procedure may act, in part, to overcome Nterminal modification. This is likely because the mutant library is displayed as an N-terminal fusion to the bulky Fos linker protein that may interfere with the receptor binding and activation domains of C5adR 74 .
The E 68 variants were antagonists of GGS-C5adR 74 , but were much less effective at antagonizing receptor activation by GGS-C5a. These data imply that the E 68 variants, particularly Variant 2 [E 68 ], have a degree of selectivity for the GGSC5adR 74 -receptor interaction even though GGS-C5a and GGSC5adR 74 are equally potent agonists for C5aR when expressed in RBL cells. Hence these antagonists may be useful tools in the analysis of the mechanism of ligand selectivity by C5aR and in the design of antagonists that target specific cell types. A C5aR antagonist has previously been produced from phage displayed libraries of C5adR 74 randomly mutated between residues 69 and 73 (Hennecke et al., 1998) . However, prior to mutagenesis these workers introduced mutations (A 27 , F 67 ) into the molecule to increase affinity and developed an antagonist based on a Fos-fused form of C5adR 74 , with a molecular weight of 18 kDa. In our approach, we have produced smaller (~9 kDa) molecules with higher affinities than GGS-C5adR 74 , without making prior assumptions about particular sequences and then introduced a single inactivating mutation (K 68 E).
In summary, a combination of random and site-directed mutation has allowed the production of a novel C5aR antagonist that shows a degree of specificity for C5adR 74 and which is amenable to refinement by further cycles of mutagenesis and selection. Additionally, the positions mutated in the selected library give important information on structure-function relationships that converges with a plethora of previous conventional studies.
